Anticancer agent 231

SKU: orb2646188

Description

Anticancer agent 231 (P5) is a small molecule that inhibits proliferation and migration in TNBC cell lines (e.g., Hs578T, MDA-MB-231) and targets the EGFR-ERK1/2 axis. It also reduces cancer stemness and can sensitize cells to paclitaxel, making it a candidate for investigating combination therapies in triple-negative breast cancer research.

Research Area

Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	128519-30-2
MW	375.89
Formula	C₂₃H₂₂ClN₃
SMILES	ClC=1C=CC(=CC1)C2=NN(C=3C=CC=CC3)C(C4=CC=C(C=C4)N(C)C)C2
Target	ERK

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

2861640 ↗

Key Properties

−

No computed properties available.

Protocol Information

Find More Protocols

CAS Number:	1394077-28-1
MW:	554.23
Formula:	C₂₅H₁₈Br₂N₂O₃

CAS Number:	2916406-04-5
MW:	435.43
Formula:	C₂₃H₂₁N₃O₆

CAS Number:	2916406-02-3
MW:	435.43
Formula:	C₂₃H₂₁N₃O₆

CAS Number:	2916404-95-8
MW:	423.44
Formula:	C₂₃H₂₂FN₃O₄

Anticancer agent 231

Description

Research Area

Images & Validation

Key Properties

Storage & Handling

Similar Products

Anticancer agent 41 [orb1686126]

Anticancer agent 158 [orb1941683]

Anticancer agent 217 [orb2564395]

Anticancer agent 216 [orb2564473]

Anticancer agent 214 [orb2564430]

Quality Guarantee

Compound Identifiers

Key Properties

Protocol Information

Available Sizes

Email

UK Office

US Office

CN Office

Distributors